Forbes October 22, 2024
Bruce Japsen

Even though Walgreens is closing 1,200 stores and potentially hundreds more, the retail pharmacy giant plans to invest in locations that remain by launching hundreds of less expensive owned brands focused on health, wellness and women’s health.

The new strategy starting to emerge this week at HLTH 2024 in Las Vegas and in calls with analysts comes on top of investments in more lucrative specialty pharmacy services while reducing debt that already decreased $1.9 billion in fiscal 2024.

“Having earned our consumers’ trust, indeed our reason to exist, we also want to be accessible and convenient, but we need to be appropriately sized,” Tim Wentworth, who took over as Walgreens chief executive officer a year ago, told analysts on the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article